Your browser doesn't support javascript.
loading
Corrigendum: The NFAT3/RERG complex in luminal breast cancers is required to inhibit cell invasion and may be correlated with an absence of axillary lymph nodes colonization.
Coillard, Lucie; Guaddachi, Frédéric; Ralu, Maëlle; Brabencova, Eva; Garbar, Christian; Bensussan, Armand; Le Bras, Morgane; Lehmann-Che, Jacqueline; Jauliac, Sébastien.
Afiliação
  • Coillard L; Université de Paris, Research Saint Louis Institute (IRSL), Institut National de la Santé et de la Recherche Médicale, Human Immunology Pathophysiology Immunotherapy (INSERM HIPI) U976, Paris, France.
  • Guaddachi F; Université de Paris, Research Saint Louis Institute (IRSL), Institut National de la Santé et de la Recherche Médicale, Human Immunology Pathophysiology Immunotherapy (INSERM HIPI) U976, Paris, France.
  • Ralu M; Université de Paris, Research Saint Louis Institute (IRSL), Institut National de la Santé et de la Recherche Médicale, Human Immunology Pathophysiology Immunotherapy (INSERM HIPI) U976, Paris, France.
  • Brabencova E; Department of Biopathology, Centre Régional de Lutte Contre le Cancer, Institut Godinot, Reims, France.
  • Garbar C; Department of Biopathology, Centre Régional de Lutte Contre le Cancer, Institut Godinot, Reims, France.
  • Bensussan A; Université de Paris, Research Saint Louis Institute (IRSL), Institut National de la Santé et de la Recherche Médicale, Human Immunology Pathophysiology Immunotherapy (INSERM HIPI) U976, Paris, France.
  • Le Bras M; Université de Paris, Research Saint Louis Institute (IRSL), Institut National de la Santé et de la Recherche Médicale, Human Immunology Pathophysiology Immunotherapy (INSERM HIPI) U976, Paris, France.
  • Lehmann-Che J; Université de Paris, Research Saint Louis Institute (IRSL), Institut National de la Santé et de la Recherche Médicale, Human Immunology Pathophysiology Immunotherapy (INSERM HIPI) U976, Paris, France.
  • Jauliac S; Molecular Oncology Unit, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Saint Louis, Paris, France.
Front Oncol ; 12: 1016189, 2022.
Article em En | MEDLINE | ID: mdl-36110951
ABSTRACT
[This corrects the article DOI 10.3389/fonc.2022.804868.].
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França